Abstract

Tobias Z, Esther D, Niklas S, et al. Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis. Ther Adv Chronic Dis 2021; 12: 1–10. DOI: 10.1177/20406223211024366
In the aforementioned article, the author names are incorrectly listed. The correct names are given as follows:
Tobias Zrzavy, Esther Daniels, Niklas Stuka, Dennis Weber, Alexander Winkelmann, Helmut Rauschka, Michael Hecker, Fahmy Aboulenein-Djamshidian, Stefanie Meister, Fritz Leutmezer, Thomas Berger, Gabriel Bsteh, Uwe Klaus Zettl, and Paulus Rommer.
The online version has also been updated.
